Brock Hardaway is the Chief Executive Officer of Alteon Health. Brock most recently served as CEO of Millennium Health, the nation’s largest specialty, clinical toxicology lab. In addition to clinical toxicology and under his leadership, the company developed a suite of genetic testing and predictive analytic products that armed healthcare providers with medication intelligence in an effort to improve medication effectiveness. Brock has also spent more than 23 years in various leadership and senior executive roles in the post-acute sector. As Executive Vice President at Kindred Healthcare, Brock had leadership responsibility for more than 60 specialty and rehab hospitals across the U.S. and managed well over $1 billion in annual revenue. Prior to the acquisition of RehabCare by Kindred, Brock was President of the Hospital Division at RehabCare where he led the day-to-day operations of the RehabCare specialty hospitals nationwide. Before joining RehabCare/Kindred, Brock was the President & COO of Triumph Healthcare, a Houston-based specialty Hospital Company. Under Brock’s leadership, Triumph grew from a small, single market player to being a national, highly regarded company that was later sold to RehabCare. Brock also held leadership roles with Select Medical Corporation, and started his successful career in the post-acute arena with Vencor. Early on, Brock worked in various aspects of healthcare consulting and gained valuable health plan experience during his time with Blue Cross Blue Shield of Texas.